Inhibikase Therapeutics Announces FDA has Lifted the Full Clinical Hold on IkT-148009 in Multiple System Atrophy
/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase...
United States Miltonh Werner Alex Lobo Inhibikase Therapeutics Inc Company Contact Drug Administration
Source: prnewswire.com